Priyanka Barman, Pritam Chakraborty, Rhea Bhaumik, Sukesh R. Bhaumik
{"title":"UPS写了一个新的传奇故事","authors":"Priyanka Barman, Pritam Chakraborty, Rhea Bhaumik, Sukesh R. Bhaumik","doi":"10.1016/j.bbagrm.2023.194981","DOIUrl":null,"url":null,"abstract":"<div><p>SAGA (<u>S</u>pt-<u>A</u>da-<u>G</u>cn5-<u>A</u><span><span>cetyltransferase), an evolutionarily conserved transcriptional co-activator among eukaryotes, is a large multi-subunit protein complex with two distinct </span>enzymatic activities, namely HAT (</span><u>H</u>istone <u>a</u>cetyl<u>t</u>ransferase) and DUB (<u>D</u>e-<u>ub</u><span>iquitinase), and is targeted to the promoter by the gene-specific activator proteins for histone covalent modifications and PIC (</span><u>P</u>re-<u>i</u>nitiation <u>c</u>omplex) formation in enhancing transcription (or gene activation). Targeting of SAGA to the gene promoter is further facilitated by the 19S RP (<u>R</u>egulatory <u>p</u><span>article) of the 26S proteasome<span> (that is involved in targeted degradation of protein via ubiquitylation) in a proteolysis-independent manner. Moreover, SAGA is also recently found to be regulated by the 26S proteasome in a proteolysis-dependent manner via the ubiquitylation of its Sgf73/ataxin-7 component that is required for SAGA's integrity and DUB activity (and hence transcription), and is linked to various diseases including neurodegenerative disorders and cancer. Thus, SAGA itself and its targeting to the active gene are regulated by the UPS (</span></span><u>U</u>biquitin-<u>p</u>roteasome <u>s</u>ystem) with implications in diseases.</p></div>","PeriodicalId":55382,"journal":{"name":"Biochimica et Biophysica Acta-Gene Regulatory Mechanisms","volume":"1866 4","pages":"Article 194981"},"PeriodicalIF":2.6000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"UPS writes a new saga of SAGA\",\"authors\":\"Priyanka Barman, Pritam Chakraborty, Rhea Bhaumik, Sukesh R. Bhaumik\",\"doi\":\"10.1016/j.bbagrm.2023.194981\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>SAGA (<u>S</u>pt-<u>A</u>da-<u>G</u>cn5-<u>A</u><span><span>cetyltransferase), an evolutionarily conserved transcriptional co-activator among eukaryotes, is a large multi-subunit protein complex with two distinct </span>enzymatic activities, namely HAT (</span><u>H</u>istone <u>a</u>cetyl<u>t</u>ransferase) and DUB (<u>D</u>e-<u>ub</u><span>iquitinase), and is targeted to the promoter by the gene-specific activator proteins for histone covalent modifications and PIC (</span><u>P</u>re-<u>i</u>nitiation <u>c</u>omplex) formation in enhancing transcription (or gene activation). Targeting of SAGA to the gene promoter is further facilitated by the 19S RP (<u>R</u>egulatory <u>p</u><span>article) of the 26S proteasome<span> (that is involved in targeted degradation of protein via ubiquitylation) in a proteolysis-independent manner. Moreover, SAGA is also recently found to be regulated by the 26S proteasome in a proteolysis-dependent manner via the ubiquitylation of its Sgf73/ataxin-7 component that is required for SAGA's integrity and DUB activity (and hence transcription), and is linked to various diseases including neurodegenerative disorders and cancer. Thus, SAGA itself and its targeting to the active gene are regulated by the UPS (</span></span><u>U</u>biquitin-<u>p</u>roteasome <u>s</u>ystem) with implications in diseases.</p></div>\",\"PeriodicalId\":55382,\"journal\":{\"name\":\"Biochimica et Biophysica Acta-Gene Regulatory Mechanisms\",\"volume\":\"1866 4\",\"pages\":\"Article 194981\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2023-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochimica et Biophysica Acta-Gene Regulatory Mechanisms\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874939923000767\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochimica et Biophysica Acta-Gene Regulatory Mechanisms","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874939923000767","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
SAGA (Spt-Ada-Gcn5-Acetyltransferase), an evolutionarily conserved transcriptional co-activator among eukaryotes, is a large multi-subunit protein complex with two distinct enzymatic activities, namely HAT (Histone acetyltransferase) and DUB (De-ubiquitinase), and is targeted to the promoter by the gene-specific activator proteins for histone covalent modifications and PIC (Pre-initiation complex) formation in enhancing transcription (or gene activation). Targeting of SAGA to the gene promoter is further facilitated by the 19S RP (Regulatory particle) of the 26S proteasome (that is involved in targeted degradation of protein via ubiquitylation) in a proteolysis-independent manner. Moreover, SAGA is also recently found to be regulated by the 26S proteasome in a proteolysis-dependent manner via the ubiquitylation of its Sgf73/ataxin-7 component that is required for SAGA's integrity and DUB activity (and hence transcription), and is linked to various diseases including neurodegenerative disorders and cancer. Thus, SAGA itself and its targeting to the active gene are regulated by the UPS (Ubiquitin-proteasome system) with implications in diseases.
期刊介绍:
BBA Gene Regulatory Mechanisms includes reports that describe novel insights into mechanisms of transcriptional, post-transcriptional and translational gene regulation. Special emphasis is placed on papers that identify epigenetic mechanisms of gene regulation, including chromatin, modification, and remodeling. This section also encompasses mechanistic studies of regulatory proteins and protein complexes; regulatory or mechanistic aspects of RNA processing; regulation of expression by small RNAs; genomic analysis of gene expression patterns; and modeling of gene regulatory pathways. Papers describing gene promoters, enhancers, silencers or other regulatory DNA regions must incorporate significant functions studies.